Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2021

May 17, 2021

SELL
$67.06 - $75.82 $5.27 Million - $5.96 Million
-78,600 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$58.54 - $67.94 $52,686 - $61,146
-900 Reduced 1.13%
78,600 $5.15 Million
Q1 2020

May 15, 2020

SELL
$49.46 - $64.78 $934,794 - $1.22 Million
-18,900 Reduced 19.21%
79,500 $4.79 Million
Q4 2019

Feb 14, 2020

BUY
$49.86 - $58.26 $1.37 Million - $1.6 Million
27,500 Added 38.79%
98,400 $5.7 Million
Q3 2019

Nov 14, 2019

SELL
$47.54 - $53.43 $2.14 Million - $2.41 Million
-45,100 Reduced 38.88%
70,900 $3.67 Million
Q2 2019

Aug 14, 2019

BUY
$46.79 - $52.47 $3.7 Million - $4.15 Million
79,100 Added 214.36%
116,000 $5.92 Million
Q1 2019

May 15, 2019

BUY
$46.36 - $52.63 $1.71 Million - $1.94 Million
36,900 New
36,900 $1.93 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $199B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Susquehanna International Securities, Ltd. Portfolio

Follow Susquehanna International Securities, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Securities, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Securities, Ltd. with notifications on news.